Multiple myeloma predominantly involving the spleen
Extramedullary disease is an uncommon manifestation in multiple myeloma (MM) and can be observed at onset or develop at disease progression or relapse. Splenic involvement is very rare. The paper describes a 52-year-old female patient with MM who in 1990 was diagnosed with monoclonal gammopathy of u...
Main Authors: | V V Ryzhko, A A Klodzinskiĭ, A E Grachev, E Iu Varlamova, M S Sataeva, I M Nakastoev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2013-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31332 |
Similar Items
-
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
by: T.B.M. Castro, et al.
Published: (2016-01-01) -
Therapeutic advancements in multiple myeloma
by: Alessandro eGozzetti, et al.
Published: (2014-09-01) -
Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01) -
Tratamento do Mieloma Múltiplo recidivado Relapsed Multiple Myeloma treatment
by: Vania T. M. Hungria
Published: (2007-03-01) -
Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study
by: Jin Lu, et al.
Published: (2016-01-01)